Naftopidil Orally Disintegrating Tablets 25mg (Flivas OD® / フリバスOD錠25mg)

JPY ¥2,400

Japanese Agent for Improvement of Dysuria Associated with Benign Prostatic Hyperplasia (Naftopidil 25mg). Oral once-daily orally disintegrating tablet for dysuria associated with benign prostatic hyperplasia. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Asahi Kasei Therapeutics Corporation, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥2,208
10 - 19 12% JPY ¥2,112
20 + 18% JPY ¥1,968
SKU: FLV-25-TAB Category:

Description

Product Overview / 商品概要

Flivas OD Tablets 25mg (フリバスOD錠25mg)
Generic: Naftopidil / ナフトピジル
Therapeutic Category: Agent for Improvement of Dysuria Associated with Benign Prostatic Hyperplasia / 前立腺肥大症に伴う排尿障害改善剤
Manufactured by: Asahi Kasei Therapeutics Corporation / 旭化成セラピューティクス株式会社

Composition & Specification / 組成・規格

Active Ingredient: Naftopidil (JP) 25mg per tablet / 1錠中 日局 ナフトピジル 25mg
Additives: Erythritol, Hydroxypropylcellulose, Sodium Stearyl Fumarate, Magnesium Stearate, Light Anhydrous Silicic Acid, l-Menthol / エリスリトール、ヒドロキシプロピルセルロース、フマル酸ステアリルナトリウム、ステアリン酸マグネシウム、軽質無水ケイ酸、l-メントール
Appearance: White orally disintegrating tablet; diameter 7.0mm, thickness 2.6mm, weight 100mg, identification code: 214
外観: 白色・口腔内崩壊錠、直径7.0mm、厚み2.6mm、重量100mg、識別コード:214

Indications / 効能効果

EN: Dysuria associated with benign prostatic hyperplasia
JA: 前立腺肥大症に伴う排尿障害

Dosage and Administration / 用法用量

EN: Usually, adults start with 25mg of Naftopidil once daily. If the effect is insufficient, the dose may be gradually increased to 50–75mg at intervals of 1–2 weeks, administered orally once daily after meals. The dose may be adjusted according to symptoms, but the maximum daily dose is 75mg.
JA: 通常、成人にはナフトピジルとして1日1回25mgより投与を始め、効果が不十分な場合は1~2週間の間隔をおいて50~75mgに漸増し、1日1回食後経口投与する。なお、症状により適宜増減するが、1日最高投与量は75mgまでとする。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22000AMX00840000
Sales Started: July 2008 / 2008年7月
Classification Code: 87259
Storage: Store at room temperature / 室温保存
Shelf Life: 36 months / 36ヵ月

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 140 tablets [14 tablets (PTP) x 10], 500 tablets [10 tablets (PTP) x 50]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Naftopidil Orally Disintegrating Tablets 25mg (Flivas OD® / フリバスOD錠25mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Naftopidil Orally Disintegrating Tablets 25mg (Flivas OD®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.